S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
NASDAQ:IART

Integra LifeSciences Stock Competitors

$67.24
+0.67 (+1.01%)
(As of 01/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$64.67
$67.40
50-Day Range
$62.47
$69.47
52-Week Range
$61.85
$77.40
Volume
489,416 shs
Average Volume
362,114 shs
Market Capitalization
$5.70 billion
P/E Ratio
26.47
Dividend Yield
N/A
Beta
1.2

Integra LifeSciences (NASDAQ:IART) Vs. ABT, MDT, ISRG, SYK, BDX, EW, BSX, IDXX, BAX, and DXCM

Should you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), and DexCom (DXCM). These companies are all part of the "health care equipment" industry.

Integra LifeSciences vs.

Integra LifeSciences (NASDAQ:IART) and Medtronic (NYSE:MDT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment.

Medtronic has a net margin of 14.80% compared to Integra LifeSciences' net margin of 14.19%. Integra LifeSciences' return on equity of 17.33% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
Integra LifeSciences 14.19% 17.33% 7.30%
Medtronic 14.80% 14.52% 8.01%

Integra LifeSciences presently has a consensus target price of $76.50, indicating a potential upside of 13.77%. Medtronic has a consensus target price of $131.62, indicating a potential upside of 26.30%. Given Medtronic's stronger consensus rating and higher probable upside, analysts plainly believe Medtronic is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences
1 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.22
Medtronic
0 Sell rating(s)
9 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.59

90.2% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 79.0% of Medtronic shares are owned by institutional investors. 4.2% of Integra LifeSciences shares are owned by insiders. Comparatively, 0.5% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Integra LifeSciences has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.

Medtronic received 1134 more outperform votes than Integra LifeSciences when rated by MarketBeat users. Likewise, 78.99% of users gave Medtronic an outperform vote while only 61.71% of users gave Integra LifeSciences an outperform vote.

CompanyUnderperformOutperform
Integra LifeSciencesOutperform Votes
419
61.71%
Underperform Votes
260
38.29%
MedtronicOutperform Votes
1553
78.99%
Underperform Votes
413
21.01%

Medtronic has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integra LifeSciences$1.37 billion4.15$133.89 million$2.5426.47
Medtronic$30.12 billion4.65$3.61 billion$3.4730.03

In the previous week, Medtronic had 8 more articles in the media than Integra LifeSciences. MarketBeat recorded 15 mentions for Medtronic and 7 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 0.46 beat Medtronic's score of -0.21 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integra LifeSciences
1 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Medtronic
0 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Medtronic beats Integra LifeSciences on 13 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

Integra LifeSciences (NASDAQ:IART) vs. Its Competitors

TypeIntegra LifeSciencesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$5.70B$3.88B$4.51B$6.94B
Dividend YieldN/A1.35%1.90%2.96%
P/E Ratio26.4724.1315.9418.37
Price / Sales4.15151.655,393.86231.90
Price / Cash16.1464.6860.3568.47
Price / Book3.747.547.438.93
Net Income$133.89M$84.13M$97.89M$156.36M
7 Day Performance-2.25%-8.17%-6.31%-6.39%
1 Month Performance-1.52%-12.29%-14.26%-11.11%
1 Year Performance-2.97%-14.52%-22.82%-11.57%

Integra LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
2.7777 of 5 stars
$123.82
+1.6%
$139.11
+12.3%
+11.5%$218.95B$34.61B30.72109,000Upcoming Earnings
MDT
Medtronic
3.6091 of 5 stars
$104.21
+1.3%
$131.62
+26.3%
-9.4%$140.12B$30.12B30.0390,000Analyst Report
ISRG
Intuitive Surgical
1.9077 of 5 stars
$271.98
+0.9%
$330.62
+21.6%
+8.7%$97.16B$4.36B58.708,081Earnings Report
Analyst Upgrade
SYK
Stryker
3.1498 of 5 stars
$251.92
+1.1%
$294.84
+17.0%
+6.1%$95.00B$14.35B50.6943,000Upcoming Earnings
BDX
Becton, Dickinson and
2.665 of 5 stars
$259.96
+1.8%
$272.43
+4.8%
+2.3%$74.10B$20.25B37.9570,000News Coverage
EW
Edwards Lifesciences
2.582 of 5 stars
$110.60
+1.9%
$126.06
+14.0%
+31.7%$69.05B$4.39B47.0614,900Upcoming Earnings
Analyst Report
Gap Down
BSX
Boston Scientific
2.3414 of 5 stars
$42.66
+0.7%
$49.90
+17.0%
+16.0%$60.79B$9.91B58.4438,000
IDXX
IDEXX Laboratories
2.4031 of 5 stars
$511.65
+1.9%
$686.40
+34.2%
+1.8%$43.38B$2.71B58.619,300
BAX
Baxter International
2.9927 of 5 stars
$85.96
+0.4%
$95.30
+10.9%
+8.5%$43.04B$11.67B35.9750,000
DXCM
DexCom
2.7679 of 5 stars
$426.83
+1.1%
$587.64
+37.7%
+14.0%$41.37B$1.93B81.616,400
RMD
ResMed
2.2165 of 5 stars
$238.52
+1.4%
$254.00
+6.5%
+9.1%$34.76B$3.20B69.957,970Upcoming Earnings
Analyst Upgrade
STE
STERIS
2.7165 of 5 stars
$224.29
+1.5%
$248.80
+10.9%
+20.6%$22.43B$3.11B80.1013,000
HOLX
Hologic
2.3075 of 5 stars
$70.89
+0.4%
$86.33
+21.8%
-6.7%$17.82B$5.63B9.855,814
PODD
Insulet
2.1637 of 5 stars
$223.00
+0.5%
$313.88
+40.8%
-22.8%$15.38B$904.40M-495.561,900
TFX
Teleflex
2.9465 of 5 stars
$317.29
+1.9%
$411.90
+29.8%
-16.4%$14.86B$2.54B34.6814,000Analyst Report
Gap Down
ABMD
Abiomed
2.2064 of 5 stars
$311.94
+2.4%
$375.50
+20.4%
-12.5%$14.19B$847.52M96.281,725Analyst Revision
MASI
Masimo
2.3231 of 5 stars
$223.51
+2.5%
$308.33
+38.0%
-17.4%$12.34B$1.14B55.745,300
GMED
Globus Medical
2.7673 of 5 stars
$68.66
+1.1%
$88.45
+28.8%
+4.0%$6.93B$789.04M37.932,200
NUVA
NuVasive
2.2869 of 5 stars
$57.50
+0.5%
$65.67
+14.2%
+1.5%$2.97B$1.05B-112.752,700
ATRC
AtriCure
2.2971 of 5 stars
$63.45
+3.2%
$86.29
+36.0%
+4.0%$2.91B$206.53M66.79750Gap Down
ITGR
Integer
2.4281 of 5 stars
$79.73
+0.0%
$108.00
+35.5%
+0.9%$2.63B$1.07B29.867,500Analyst Revision
ATEC
Alphatec
2.4148 of 5 stars
$10.59
+3.3%
$18.83
+77.8%
-30.9%$1.05B$144.86M-7.41296Gap Down
ANGO
AngioDynamics
2.3181 of 5 stars
$22.82
+3.1%
$32.00
+40.2%
+21.5%$883.52M$291.01M-23.05800
CSII
Cardiovascular Systems
2.0219 of 5 stars
$18.79
+3.8%
$43.40
+131.0%
-61.3%$761.95M$258.97M-36.84779Gap Down
CRY
CryoLife
2.6248 of 5 stars
N/A$32.00
+∞
-29.2%$703.22M$253.23M596.201,200
OFIX
Orthofix Medical
1.4931 of 5 stars
$32.00
+1.2%
N/A-28.0%$631.84M$406.56M-41.561,036
SRDX
Surmodics
2.2314 of 5 stars
$44.39
+1.0%
$70.00
+57.7%
-4.2%$620.35M$105.14M147.97370
ARAY
Accuray
2.6214 of 5 stars
$4.24
+4.5%
$7.50
+76.9%
-20.7%$385.50M$396.29M-53.00932Upcoming Earnings
IVC
Invacare
1.8031 of 5 stars
$2.66
+1.9%
$8.50
+219.5%
-73.7%$93.16M$850.69M-1.753,400Analyst Revision
Gap Down
RMTI
Rockwell Medical
1.6781 of 5 stars
$0.38
+2.6%
$3.00
+688.6%
-72.3%$35.75M$62.20M-1.12300Analyst Downgrade
Gap Down
This page was last updated on 1/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.